TRIBTRINITY BIOTECH PLCvs its industry peers
A metric-by-metric comparison of TRINITY BIOTECH PLC against SIC 2835 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TRIBThis | $2.8B#1 | — | — | 45.6x#4 | 8.3%#2 | -32.4%#5 | -34.4%#1 | — | — | — | — | 0.2%#1 |
| TKNO | $391M#2 | — | 6.3x#3 | 9.7x#2 | 7.4%#3 | 35.5%#2 | -41.9%#2 | -27.6%#1 | -25.2%#1 | 5#1 | — | — |
| ICCC | $95M#3 | — | — | — | — | — | — | — | — | — | 68.6%#1 | — |
| IMDX | $94M#4 | — | — | 23.2x#3 | 115.6%#1 | 17.2%#3 | -1260.8%#4 | — | — | — | -53.0%#2 | — |
| QCLS | $3M#5 | 0.0x#1 | 0.2x#2 | 2.2x#1 | -5.3%#4 | 50.2%#1 | -624.4%#3 | -72.3%#2 | -61.2%#2 | — | — | — |
| VRAX | $677685#6 | — | 0.1x#1 | 107.0x#5 | -96.0%#5 | 10.0%#4 | -97344.8%#5 | -106.4%#3 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2835). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice